EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 31-Dec-2025 14:11 ET (31-Dec-2025 19:11 GMT/UTC)

Adding cell-based vaccine to liver cancer therapy slows cancer progression in patients with liver cancer

University of Birmingham
Peer-Reviewed Publication

Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumour progression in response to standard treatment according to a new study funded by the National Institute for Health and Care Research and led by the University of Birmingham.

Journal: Clinical Cancer Research

New ATA management guidelines for adult patients with differentiated thyroid cancer

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

The American Thyroid Association has released new guidelines for the management of adult patients with differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid. The guidelines are published in the peer-reviewed journal Thyroid^®, the official journal of the American Thyroid Association^® (ATA^®).

Journal: Thyroid

Qigong and Taichi act as ‘painkillers’ for cancer patients?

Shanghai Jiao Tong University Journal Center
Peer-Reviewed Publication

Current international guidelines encourage cancer patients to engage in physical activity and recommend mind-body therapies (MBTs) as a method for treating cancer-related pain (CRP). However, the most effective MBTs for improving CRP in this population remain unknown. Therefore, this network meta-analysis (NMA) aimed to assess and rank the relative efficacy of different MBTs for CRP, and to conduct subgroup analyses according to different cancer types and stages of treatment.

Journal: Translational Exercise Biomedicine

Bar-Ilan University joins €8 million European consortium to make life-saving CAR-T cancer therapy faster, safer, and more accessible

Bar-Ilan University
Business Announcement

Bar-Ilan University has joined a major new €8 million European initiative aimed at revolutionizing how personalized cancer treatments like CAR-T cell therapy are delivered in hospitals. Funded by the EU-backed Innovative Health Initiative (IHI), the five-year project—called EASYGEN (Easy workflow integration for gene therapy)—will develop a fully automated system that allows hospitals to manufacture CAR-T therapies on-site in just 24 hours instead of weeks.

Novel study reveals three new follicular lymphoma subtypes guides precision treatment

BGI Genomics
Peer-Reviewed Publication

A new study has identified three distinct molecular subtypes of follicular lymphoma (FL), offering insights that may shape future precision diagnostics and personalized treatment plans for patients across Asia and the West.

The research was jointly conducted by scientists at BGI Genomics' Institute of Intelligent Medical Research (IIMR) and Sweden's Karolinska Institutet, published in Cell Reports Medicine early August.

Journal: Cell Reports Medicine

Scientists discover how genetic mutations drive Weaver syndrome, with implications for overgrowth disorders and cancer risk

Trinity College Dublin
Peer-Reviewed Publication

Scientists have discovered how mutations in a specific gene drive the rare developmental disorder Weaver syndrome, which is marked by intellectual disability and overgrowth and predisposes people with the condition to cancer.

Journal: Genes & Development

Cellular memory: The clever strategy cells use to move through narrow environments

University of Basel
Peer-Reviewed Publication

In wound healing, immune response, and cancer metastasis, cells migrate through the body – often squeezing through narrow, confined spaces. Together with experimental collaborators, Professor David Brückner at the University of Basel, Switzerland, has discovered that cells possess a kind of memory: they can “remember” how they previously navigated such constrictions. This allows them to move more quickly and efficiently through complex tissues.

Journal: Nature Physics

EBMT partners in a new consortium to decentralise CAR-T cell therapy and improve hospital workflow

European Society for Blood and Marrow Transplantation
Business Announcement

The newly launched EASYGEN (Easy workflow integration for gene therapy) consortium will develop a fully automated, hospital-based platform capable of manufacturing personalised cell therapies within a few days. Fresenius SE & Co. KGaA is leading this €8 million EU-backed effort to make CAR-T cell therapy faster, more affordable, and more accessible to patients across Europe. As one of the eighteen consortium partners, EBMT will participate in a study examining current CAR-T treatment processes. EBMT will conduct a literature review on the quality of life of patients treated under existing CAR-T delivery models and will also contribute to patient education and advocacy efforts.

BU study finds type 2 diabetes blood factors drive breast cancer aggression

Boston University School of Medicine
Peer-Reviewed Publication

People with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no one knows exactly why. A new study by researchers at Boston University Chobanian & Avedisian School of Medicine and published in Springer Nature found that tiny particles in the blood, known as exosomes, which are altered by diabetes, can reprogram immune cells inside tumors making them weaker and allowing the cancer to grow and spread more easily.

Journal: Communications Biology

A natural compound could help fight aggressive leukemia and amplify the effect of chemotherapy drugs

University of Surrey
Peer-Reviewed Publication

Forskolin, a natural compound derived from a plant, could significantly improve treatment outcomes for an aggressive form of leukaemia, known as KMT2A-rearranged Acute Myeloid Leukaemia (KMT2A-r AML), according to a new study from the University of Surrey.

Journal: British Journal of Pharmacology